{"doi":"10.1016/j.arthro.2024.09.008","title":"Anterior Cruciate Ligament Repair Results in Similar Patient‐Reported Outcome Measures as Anterior Cruciate Ligament Reconstruction: A Systematic Review of Prospective Comparative Studies","abstract":"PURPOSE: To investigate the patient-reported outcomes (PROs), knee stability, and complications in prospective comparative studies of patients undergoing augmented anterior cruciate ligament (ACL) repair compared with anterior cruciate ligament reconstruction (ACLR). METHODS: A literature search was performed according to the 2020 Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Human clinical studies of Level I-II evidence comparing PROs, knee stability, and complications after ACL repair and reconstruction were included, and a qualitative analysis was performed. Excluded studies included those lacking reporting outcomes, studies that performed open ACLR or repair, studies published before the year 2000, and studies with evidence Levels III-IV. Study quality was assessed using the Cochrane Collaboration's risk of bias tool. RESULTS: Seven Level I-II studies were retained, comprising 190 ACLR and 221 repairs (75 bridge-enhanced ACL repair [BEAR], 49 suture augmentation [SA], and 97 dynamic intraligamentary stabilization [DIS]). At final follow-up, re-rupture rates varied between 0 and 14% (BEAR) versus 0 and 6% (ACLR) and mean side-to-side differences measured using KT-1000 testing ranged from 1.6 to 1.9 mm (BEAR) versus 1.7 to 3.14 mm (ACLR). For DIS versus ACLR, mean anterior tibial translation values at final follow-up were 1.7 mm (DIS) versus 1.4 mm (ACLR), and re-rupture rates ranged from 20.8% to 29% (DIS) versus 17% to 27.2% (ACLR). For SA versus ACLR, the mean side-to-side difference ranged from 0.2 to 0.39 mm (SA) versus 0.33 to 0.4 mm (ALCR), whereas the re-rupture rates were 10% (SA) versus 0% (ACLR). International Knee Documentation Committee, Tegner, Lysholm, and Knee Injury and Osteoarthritis Outcome scores across both cohorts exhibited statistically significant, and comparable improvement, from baseline to final follow-up ranging from 1 to 5 years. CONCLUSIONS: Augmented ACL repair results in similar patient-reported outcome measures in comparison with ACLR. However, augmented ACL repair may be associated with greater rates of failure, given re-rupture rates of up to 14%, 29%, and 10% for BEAR, DIS, and SA, respectively. LEVEL OF EVIDENCE: Level II, systematic review of Level I-II studies.","journal":"Arthroscopy The Journal of Arthroscopic and Related Surgery","year":2024,"id":432459,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":15,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9138,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2024-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1237025,"name":"Juan Bernardo Villarreal‐Espinosa","orcid":"0009-0006-8272-592X","position":1,"is_corresponding":false},{"id":1237026,"name":"Lucas Pallone","orcid":"0009-0002-6622-9089","position":2,"is_corresponding":false},{"id":949363,"name":"Eric J. Cotter","orcid":"0000-0003-2206-8754","position":3,"is_corresponding":false},{"id":1237027,"name":"Jonathan Spaan","orcid":"0000-0002-5148-5680","position":4,"is_corresponding":false},{"id":1237028,"name":"Ashwinee Manivannan","orcid":"0009-0008-7773-3970","position":5,"is_corresponding":false},{"id":1107630,"name":"Garrett R. Jackson","orcid":"0000-0002-7018-8382","position":6,"is_corresponding":false},{"id":1237029,"name":"José Rafael García","orcid":"0000-0003-1092-3899","position":7,"is_corresponding":false},{"id":1237030,"name":"Salvador González Ayala","orcid":"0000-0002-3166-4278","position":8,"is_corresponding":false},{"id":286517,"name":"Nikhil N. Verma","orcid":"0000-0001-9875-2769","position":9,"is_corresponding":false},{"id":286518,"name":"Brian J. Cole","orcid":"0000-0002-4006-2113","position":10,"is_corresponding":false},{"id":286519,"name":"Jorge Chahla","orcid":"0000-0002-9194-1150","position":11,"is_corresponding":false},{"id":1237024,"name":"Rodrigo Saad Berreta","orcid":"0000-0002-6019-7509","position":0,"is_corresponding":true}],"reference_count":60,"raw_metadata":null,"created_at":"2026-07-19T01:59:35.267142Z","pmid":"39276949","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}